ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Pharmaceutical R&D for Low-Income Countries

Has the current portfolio of public, non-profit and private sector research initiatives, together with the extension of stronger intellectual property rights, been associated with any discernible change in broad based measures of R&D activity targeted at poor country markets? This paper is a follow-up to a 2001 baseline study of existing and historical R&D patterns and it revisits and updates the statistical series and reports on a second wave of R&D activity by Indian pharmaceutical firms. Taken as a whole, the various data sources examined in the paper point to a steady increase in pharmaceutical inventive activity in some areas of specific interest to developing countries. The set of diseases still in need of better low-cost treatments has seen a trend increase in its share of patenting and bibliometric citation. While overall investment in pharmaceutical R&D in India surged over the past five years, it became less targeted towards the health needs of the developing world.

To read the full text Login

To know more about our subscription offers Click Here.


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top